Zila, Inc.

Zila, Inc. is a progressive corporation, bringing needed pharmaceutical, biomedical, dental and nutritional products to professionals and consumers worldwide.
With three operating groups - Pharmaceuticals, Professional Products and Nutraceuticals - Zila influences diverse aspects of diagnosis, care and management in dentistry, medicine and nutrition. Success stories range from cold sore relief to life-saving early detection of oral cancer. Zila has an enviable growth history, tied to line extensions and expanding market share for core non-prescription products, plus timely acquisitions of synergistic products and companies. Zilactin is the mouth sore treatment recommended by more pharmacists than any other for three consecutive years. The Zilactin family of six patented, clinically-proven products offers an effective range of solutions. Peridex is a prescription mouth rinse that is used between dental visits as part of a professional program to treat gingivitis. Inflamed and bleeding gums are the primary characteristics of gingivitis.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Bio
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Prescription drugs (Rx)

Therapeutic targets:

- Cancer
- Orthopedics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: